Mariner
MEDP icon

Mariner’s Medpace MEDP Stock Holding History

Mariner’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2M Buy
39,977
+2,197
+6% +$1.12M 0.02% 481
2025
Q4 		$21.2M Buy
37,780
+22,942
+155% +$13M 0.03% 431
2025
Q3 		$7.63M Buy
14,838
+8,808
+146% +$3.85M 0.01% 739
2025
Q2 		$1.89M Buy
6,030
+1,568
+35% +$471K ﹤0.01% 1370
2025
Q1 		$1.36M Buy
4,462
+1,637
+58% +$551K ﹤0.01% 1477
2024
Q4 		$939K Buy
2,825
+840
+42% +$285K ﹤0.01% 1707
2024
Q3 		$662K Buy
1,985
+275
+16% +$104K ﹤0.01% 1918
2024
Q2 		$704K Buy
1,710
+513
+43% +$203K ﹤0.01% 1769
2024
Q1 		$484K Sell
1,197
-799
-40% -$281K ﹤0.01% 2045
2023
Q4 		$612K Buy
1,996
+600
+43% +$162K ﹤0.01% 1807
2023
Q3 		$338K Sell
1,396
-118
-8% -$30.2K ﹤0.01% 2056
2023
Q2 		$364K Buy
1,514
+3
+0.2% +$623 ﹤0.01% 1974
2023
Q1 		$284K Sell
1,511
-431
-22% -$89.1K ﹤0.01% 2117
2022
Q4 		$413K Buy
1,942
+324
+20% +$64.7K ﹤0.01% 1778
2022
Q3 		$254K Buy
+1,618
New +$258K ﹤0.01% 1890

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Mariner's MEDP Position: Q1 2026 in Review

Mariner increased its Medpace (MEDP) stake by 5.8% in Q1 2026, buying an estimated $1.12M and bringing the position to 39,977 shares worth $19.2M. The position accounts for 0.02% of the portfolio, ranked #481.

Mariner first reported a position in MEDP in Q3 2022 and has held it in 15 quarters since. The position peaked at $21.2M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Mariner held 39,977 shares of Medpace worth $19.2M as of Q1 2026.
  • Mariner bought 2,197 Medpace shares in Q1 2026, an estimated $1.12M.
  • Medpace made up 0.02% of Mariner's portfolio in Q1 2026, its #481 holding.
  • Mariner first reported a position in Medpace in Q3 2022 and has held it in 15 quarters since.
  • Mariner's Medpace position peaked at $21.2M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.